冠状动脉疾病中的抗凝治疗：一个治疗难题。
ANTICOAGULANT THERAPY IN CORONARY ARTERY DISEASE: A THERAPEUTIC ENIGMA.
作者信息
BROWN K W, MACMILLAN R L
出版信息
Can Med Assoc J. 1965 Jan 9;92(2):70-2.
Abstract
The authors' experience with anticoagulant therapy in both the acute phase and the long-term management of myocardial infarction has proved disappointing. A review of the literature has failed to establish benefit when all patients with coronary artery disease are treated with anticoagulant drugs. A need for well-controlled studies still exists.
摘要
作者在心肌梗死急性期和长期管理中使用抗凝治疗的经验令人失望。对文献的回顾未能证实对所有冠心病患者使用抗凝药物有好处。仍然需要进行严格对照的研究。
相似文献
1
ANTICOAGULANT THERAPY IN CORONARY ARTERY DISEASE: A THERAPEUTIC ENIGMA.冠状动脉疾病中的抗凝治疗：一个治疗难题。
Can Med Assoc J. 1965 Jan 9;92(2):70-2.
2
HEPARIN VERSUS ORAL ANTICOAGULANT THERAPY IN CORONARY ATHEROSCLEROSIS: REVIEW OF ADVANTAGES AND DISADVANTAGES.肝素与口服抗凝剂治疗冠状动脉粥样硬化：优缺点综述
South Med J. 1964 Mar;57:292-6. doi: 10.1097/00007611-196403000-00012.
3
Anticoagulant drug treatment of coronary artery disease.冠状动脉疾病的抗凝药物治疗。
Calif Med. 1959 Mar;90(3):197-201.
4
CURRENT MYTHS AND REALITIES IN ANTICOAGULANT THERAPY FOR CORONARY HEART DISEASE.冠心病抗凝治疗中的当前误区与现实
Med Clin North Am. 1964 Mar;48:355-70.
5
INITIAL HEPARIN THERAPY IN ACUTE MYOCARDIAL INFARCTION.急性心肌梗死的初始肝素治疗
Can Med Assoc J. 1964 Jun 13;90(24):1345-8.
6
THE ROLE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION.抗凝治疗在心肌梗死治疗中的作用
Geriatrics. 1965 Feb;20:150-5.
7
The prevention of impending cardiac infarction by anticoagulant treatment.通过抗凝治疗预防即将发生的心肌梗死。
Br Heart J. 1951 Oct;13(4):467-74. doi: 10.1136/hrt.13.4.467.
8
[PROPAGATION OF THE USE OF ANTICOAGULANT THERAPY IN HUNGARY AND SOME CURRENT PROBLEMS].
Orv Hetil. 1964 Nov 22;105:2215-8.
9
MYOCARDIAL INFARCTION DURING LONG-TERM ANTICOAGULANT THERAPY.长期抗凝治疗期间的心肌梗死
Acta Med Scand. 1964 Dec;176:693-700. doi: 10.1111/j.0954-6820.1964.tb00676.x.
10
Late results of treatment in myocardial infarction; effect of short-term anticoagulant therapy on the mortality at one year.心肌梗死治疗的远期结果；短期抗凝治疗对一年死亡率的影响。
Lancet. 1954 Sep 4;267(6836):465-8. doi: 10.1016/s0140-6736(54)91877-2.
本文引用的文献
1
Anticoagulants in coronary thrombosis with myocardial infarction.心肌梗死伴冠状动脉血栓形成时的抗凝剂
AMA Arch Intern Med. 1951 Aug;88(2):207-10. doi: 10.1001/archinte.1951.03810080075008.
2
Further observations on the value of anticoagulant therapy in the treatment of acute myocardial infarction.关于抗凝治疗在急性心肌梗死治疗中价值的进一步观察
Scott Med J. 1961 Dec;6:559-64. doi: 10.1177/003693306100601203.
3
INITIAL HEPARIN THERAPY IN ACUTE MYOCARDIAL INFARCTION.急性心肌梗死的初始肝素治疗
Can Med Assoc J. 1964 Jun 13;90(24):1345-8.
4
Protection by anti-mineralocorticoid against an otherwise fatal dihydrotachysterol intoxication.抗盐皮质激素对原本致命的二氢速甾醇中毒的保护作用。
Lancet. 1960 Dec 17;2(7164):1350-1. doi: 10.1016/s0140-6736(60)92550-2.
5
Anticoagulants in acute myocardial infarction.
Lancet. 1961 Aug 12;2(7198):327-31. doi: 10.1016/s0140-6736(61)90629-8.
6
The influence of artificial expiratory stenoses and of rebreathing on the mean capacity in asthma and emphysema.人工呼气狭窄和重复呼吸对哮喘及肺气肿平均肺容量的影响。
Acta Med Scand. 1960 Sep 21;168:1-5. doi: 10.1111/j.0954-6820.1960.tb06632.x.
7
The prevention of myocardial infarction.心肌梗死的预防
AMA Arch Intern Med. 1957 Dec;100(6):959-64. doi: 10.1001/archinte.1957.00260120103012.
8
The choice of an anticoagulant.抗凝剂的选择。
Am J Med Sci. 1954 May;227(5):526-9. doi: 10.1097/00000441-195405000-00006.
Zotero 插件